期刊文献+

游离脂肪酸通过刺激整合素连接激酶表达促进肾癌786-O细胞增殖

Free fatty acids induce proliferation of human renal carcinoma 786-O cell line via integrin-linked kinase
下载PDF
导出
摘要 目的:探讨游离脂肪酸(free fatty acids,FFAs)异常对人肾癌786-O细胞增殖以及整合素连接激酶(inte-grin-linked kinase,ILK)蛋白表达的影响。方法:分别用0、0.05、0.1和0.2 mmol/L的油酸(oleic acid,OA)作用人肾癌786-O细胞48 h,其中0 mmol/L组作为对照组。利用MTT方法检测各组细胞增殖情况,流式细胞仪检测各组细胞凋亡情况,Western blot方法检测各组细胞中ILK、Akt和p-Akt蛋白的表达水平。结果:MTT检测结果显示,0.05、0.1和0.2 mmol/L OA组与对照组相比,细胞增殖活性显著增高(光密度0.657±0.056、0.682±0.028、0.718±0.042 vs.0.495±0.034,P均<0.001);而不同浓度的OA对786-O细胞的凋亡作用并不明显(凋亡率2.42%±0.25%vs.2.33%±0.87%vs.2.25%±0.51%,P=0.082);与对照组相比,OA组中的ILK、p-Akt蛋白表达显著上调。结论:FFAs通过刺激ILK/Akt通路可促进细胞增殖,可能与肾癌发生有关。 Objective:To investigate the effects of free fatty acids on cell proliferation and integrin-linked kinase (ILK) expression in human renal carcinoma 786-O cell line. Methods: The 786-O cells were exposed to normal medium and different concentrations of oleic acid (OA) carried by de-fatty bo-vine serum albumin (d-BSA). The MTY assay and the flow cytometry assay were performed respectively for cell proliferation and apoptosis after the treatment with OA for 48 h. The expressions of ILK, Akt and p-Akt were detected by Western blot. Results: The MTT assay showed that the cell viabilities of O. 05 mmol/L, 0.1 mmoL/L and 0.2 mmol/L OA groups were increased gradually, as compared with the blank control (absorbance: 0.657 ±0. 056, 0. 682 ±0. 028, 0. 718 ±0. 042 vs. O. 495 ±0. 034; all P 〈 0. 001 ). The effects of OA on cells apoptosis were not significant (apoptotic rates: 2.42% ± 0.25% vs. 2.33% ±.87% vs. 2.25% ±0.51%, P =0. 082). After being treated with OA, the expressions of ILK and p-Akt were increased in 786-O cells. Conclusion: The results suggested that free fatty acids could promote the development of renal cell carcinoma via up-regulating ILK/Akt pathway, which may reveal the relations between metabolic disturbance and renal carcinoma to a certain extent.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2013年第2期217-220,共4页 Journal of Peking University:Health Sciences
基金 国家自然科学基金(31171341)资助~~
关键词 油酸 肾细胞 细胞增殖 整合素连接激酶 Oleic acid Carcinoma, renal cell Cell proliferation Integrin-linked kinase
  • 相关文献

参考文献20

  • 1Jemal A, Bray F, Center M, et al. Global cancer statistics [ J ]. CA Cancer J Clin, 2011, 61 (2) : 69 -90.
  • 2马建辉,李鸣,张思维,那彦群,陈万青.中国部分市县肾癌及泌尿系其他恶性肿瘤发病趋势比较研究[J].中华泌尿外科杂志,2009,30(8):511-514. 被引量:52
  • 3Tolie A, Jung M, Lein M, et al. Brain-type and liver-type fatty acid-binding proteins: new tumor markers tor renal cancer? [ J ]. BMC Cancer, 2009, 21 (9): 248-260.
  • 4Onitilo AA, Engel JM, Glurich I, et al. Diabetes and cancer Ⅰ: risk, survival, and implications for screening [ J ]. Cancer Cause Control, 2012, 23(6): 967-981.
  • 5Soto-Guzman A, Navarro-Tito N, Castro-Sanchez L, et al. Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells[J]. Clin Exp Metastasis, 2010, 27(7): 505 -515.
  • 6Suburu J, Chen YQ. Lipids and prostate cancer [ J ]. Prostaglandins Other Lipid Mediat, 2012, 98( 1 -2) : 1 - 10.
  • 7McDonald PC, Oloumi A, Mills J, et al. Rictor and integrinlinked kinase interact and regulate Akt phosphorylation and cancer cell survival [J]. Cancer Res, 2008, 68(6) : 1618 - 1624.
  • 8Khan WA, Blobe GC, Hannun YA. Arachidonic acid and flee fatty acids as second messengers and the role of protein kinase C [J]. Cell Signal, 1995, 7(3) : 171 -184.
  • 9Yun MR, l,ee JY, Park HS, et al. Oleic acid enhances vascular smooth muscle cell proliteration via phosphatidylinositol 3-kinase/ Akt signaling pathway [ J]. Pharmacol Res, 2006, 54(2): 97 - 102.
  • 10Vinciguerra M, Carrozzino F, Peyrou M, et al. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN [ J ]. J Hepatol. 2009, 50(6) : 1132 -1141.

二级参考文献14

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon:IARC, 1991:101 -107.
  • 6Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon: IARC, 1994: 35 -49.
  • 7Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005:11 38.
  • 8Felay J. The IARCcrgTools program, http://www, iacr. com. fr/ iarccrgtools, htm. IACR. Lyon. 2006.
  • 9Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. Ⅷ. IARC Scientific Publication No. 155. Lyon:IARC, 2002: 745-747.
  • 10Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部